X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2916) 2916
Newsletter (206) 206
Publication (195) 195
Book Review (20) 20
Book / eBook (14) 14
Book Chapter (14) 14
Conference Proceeding (8) 8
Newspaper Article (6) 6
Magazine Article (4) 4
Dissertation (3) 3
Government Document (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
animals (1479) 1479
humans (1417) 1417
porphyrins (1007) 1007
photodynamic therapy (985) 985
male (962) 962
female (937) 937
index medicus (912) 912
photochemotherapy (860) 860
mice (665) 665
cancer (642) 642
photosensitizing agents - administration & dosage (571) 571
porphyrins - administration & dosage (569) 569
rats (488) 488
photochemotherapy - methods (470) 470
porphyrins - therapeutic use (430) 430
photosensitizing agents - therapeutic use (401) 401
biochemistry & molecular biology (353) 353
middle aged (346) 346
oncology (342) 342
cell line, tumor (323) 323
porphyrin (323) 323
porphyrins - metabolism (316) 316
fluorescence (304) 304
aged (297) 297
adult (294) 294
porphyrins - pharmacology (293) 293
pharmacology & pharmacy (286) 286
treatment outcome (285) 285
porphyrins - chemistry (271) 271
ophthalmology (259) 259
photosensitizing agents - pharmacology (254) 254
5-aminolevulinic acid (241) 241
research (241) 241
time factors (233) 233
biophysics (228) 228
light (228) 228
tumors (212) 212
verteporfin (207) 207
nanoparticles (202) 202
porphyrins - pharmacokinetics (194) 194
photosensitizing agents - chemistry (189) 189
dose-response relationship, drug (184) 184
care and treatment (181) 181
photosensitizing agents - pharmacokinetics (181) 181
chemistry, multidisciplinary (178) 178
therapy (178) 178
in-vivo (177) 177
mice, inbred balb c (175) 175
cells (170) 170
macular degeneration (165) 165
choroidal neovascularization - drug therapy (164) 164
analysis (162) 162
cell survival - drug effects (161) 161
porphyrins - urine (161) 161
fluorescein angiography (160) 160
in-vitro (158) 158
apoptosis (156) 156
liver - metabolism (154) 154
photosensitizers (149) 149
tissue distribution (149) 149
photosensitizer (147) 147
aminolevulinic acid - administration & dosage (146) 146
surgery (146) 146
mice, nude (143) 143
aged, 80 and over (142) 142
disease models, animal (138) 138
lasers (133) 133
follow-up studies (132) 132
tumor (125) 125
macular degeneration - drug therapy (124) 124
drug delivery systems (123) 123
health aspects (120) 120
liver - drug effects (119) 119
drugs (118) 118
oxidative stress (118) 118
article (114) 114
liposomes (112) 112
toxicology (109) 109
visual acuity (105) 105
proteins (103) 103
kinetics (101) 101
rats, wistar (101) 101
tomography, optical coherence (101) 101
liver - enzymology (100) 100
aminolevulinic acid - pharmacology (99) 99
apoptosis - drug effects (99) 99
neoplasms - drug therapy (99) 99
porphyrins - biosynthesis (99) 99
photosensitization (98) 98
choroidal neovascularization - etiology (97) 97
macular degeneration - complications (97) 97
toxicity (97) 97
carcinoma (95) 95
administration, oral (94) 94
chemistry, physical (94) 94
retrospective studies (94) 94
singlet oxygen (94) 94
delivery (93) 93
drug-delivery (93) 93
dermatology (91) 91
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3026) 3026
German (54) 54
Japanese (23) 23
French (18) 18
Russian (15) 15
Chinese (8) 8
Italian (7) 7
Spanish (6) 6
Czech (4) 4
Polish (3) 3
Croatian (1) 1
Dutch (1) 1
Norwegian (1) 1
Portuguese (1) 1
Romanian (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Advanced Materials, ISSN 0935-9648, 06/2014, Volume 26, Issue 21, pp. 3433 - 3440
MoS2 nanosheets functionalized with poly­ethylene glycol are for the first time used as a multifunctional drug delivery system with high drug loading... 
MoS2 nanosheet | combination therapy | drug delivery | 2D nanostructure | photothermal therapy | GRAPHENE OXIDE | CELLS | PHYSICS, CONDENSED MATTER | PHYSICS, APPLIED | MATERIALS SCIENCE, MULTIDISCIPLINARY | CHEMISTRY, PHYSICAL | METAL DICHALCOGENIDE NANOSHEETS | NANOSCIENCE & NANOTECHNOLOGY | TUMOR VASCULATURE | CHEMISTRY, MULTIDISCIPLINARY | NANOPARTICLES | THERAPY | NANOGRAPHENE | CHEMISTRY | NANOTUBES | Molybdenum - chemistry | Drug Carriers - adverse effects | Porphyrins - administration & dosage | Humans | Polyethylene Glycols - adverse effects | Polyethylene Glycols - chemistry | Antineoplastic Agents - administration & dosage | Porphyrins - pharmacokinetics | Radiation-Sensitizing Agents - pharmacokinetics | Drug Carriers - chemistry | Phototherapy - methods | Molybdenum - adverse effects | Radiation-Sensitizing Agents - administration & dosage | Disulfides - chemistry | Camptothecin - administration & dosage | Female | Nanostructures - adverse effects | Antineoplastic Agents - pharmacokinetics | Camptothecin - analogs & derivatives | Doxorubicin - administration & dosage | Camptothecin - pharmacokinetics | Cell Survival - drug effects | KB Cells | Disulfides - adverse effects | Combined Modality Therapy | Disulfides - chemical synthesis | Doxorubicin - pharmacokinetics | Mammary Neoplasms, Experimental - therapy | Pilot Projects | Animals | Cell Line, Tumor | Nanostructures - chemistry | Mice | Mice, Inbred BALB C | Polyethylene Glycols - chemical synthesis | HeLa Cells | Drugs | Chemotherapy | Drug delivery systems | Vehicles | Cancer
Journal Article
Journal of Controlled Release, ISSN 0168-3659, 10/2017, Volume 263, pp. 79 - 89
The abnormal tumor microenvironment (TME) featured with hypoxia, acidosis, dense extracellular matrix and increased tumor interstitial fluid pressure is... 
Albumin | Deep penetration | Hypoxia relieve | Self-assembly | Combination therapy | PHOTODYNAMIC THERAPY | CHEMISTRY, MULTIDISCIPLINARY | CANCER-THERAPY | OXYGEN | NANOPARTICLES | GUIDED PHOTOTHERMAL THERAPY | MICROENVIRONMENT | PHARMACOLOGY & PHARMACY | HYDROGEN-PEROXIDE | ENZYME ENCAPSULATION | RADIOTHERAPY | Neoplasms - metabolism | Porphyrins - administration & dosage | Catalase - therapeutic use | Theranostic Nanomedicine | Nanoparticles - chemistry | Porphyrins - chemistry | Serum Albumin - administration & dosage | Tumor Microenvironment | Hydrogen Peroxide - chemistry | Radiation-Sensitizing Agents - therapeutic use | Paclitaxel - chemistry | Antineoplastic Agents, Phytogenic - administration & dosage | Neoplasms - therapy | Radiation-Sensitizing Agents - administration & dosage | Nanoparticles - therapeutic use | Female | Radiation-Sensitizing Agents - chemistry | Antineoplastic Agents, Phytogenic - therapeutic use | Paclitaxel - administration & dosage | Serum Albumin - chemistry | Porphyrins - therapeutic use | Antineoplastic Agents, Phytogenic - chemistry | Combined Modality Therapy | Paclitaxel - therapeutic use | Serum Albumin - therapeutic use | Catalase - administration & dosage | Animals | Mice, Nude | Cell Line, Tumor | Hypoxia | Nanoparticles - administration & dosage | Neoplasms - pathology | Catalase - chemistry | Chemotherapy | Pharmaceutical industry | Cancer | Enzymes
Journal Article
Journal Article
Cancer, ISSN 0008-543X, 02/2012, Volume 118, Issue 4, pp. 1062 - 1074
Journal Article
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2007, Volume 67, Issue 2, pp. 573 - 580
Journal Article
Journal Article
Journal of Controlled Release, ISSN 0168-3659, 11/2015, Volume 218, pp. 63 - 71
Journal Article
Biomaterials, ISSN 0142-9612, 2016, Volume 104, pp. 339 - 351
Journal Article
Molecular Cancer Therapeutics, ISSN 1535-7163, 11/2017, Volume 16, Issue 11, pp. 2422 - 2431
Vascular-targeted photodynamic therapy (PDT) selectively disrupts vascular function by inducing oxidative damages to the vasculature, particularly endothelial... 
CARCINOMA XENOGRAFTS | PROSTATE | PD-BACTERIOPHEOPHORBIDE TOOKAD | VERTEPORFIN | PI3K | ONCOLOGY | PANCREATIC-CANCER | TUMOR-CELLS | DRUG-RESISTANCE | PHASE I/II | INHIBITOR | Porphyrins - administration & dosage | Apoptosis - drug effects | Humans | Imidazoles - administration & dosage | Neoplasm Recurrence, Local - drug therapy | Thiazoles - administration & dosage | Phosphatidylinositol 3-Kinases - antagonists & inhibitors | Quinolines - administration & dosage | Photochemotherapy | Neovascularization, Pathologic - pathology | Neoplasm Recurrence, Local - pathology | Neoplasms - genetics | Verteporfin | Aminopyridines - administration & dosage | Morpholines - administration & dosage | Combined Modality Therapy | Myeloid Cell Leukemia Sequence 1 Protein - genetics | Neoplasms - drug therapy | Phosphatidylinositol 3-Kinases - genetics | Xenograft Model Antitumor Assays | Protein Kinase Inhibitors - administration & dosage | Animals | Signal Transduction - drug effects | Neovascularization, Pathologic - drug therapy | Cell Line, Tumor | Neoplasm Recurrence, Local - genetics | Neovascularization, Pathologic - genetics | Cell Proliferation - drug effects | Mice | Oxidative Stress - drug effects | Endothelial Cells - pathology | Neoplasms - pathology | Endothelial Cells - drug effects | TOR protein | Cell proliferation | Cell survival | Photodynamic therapy | Bcl-2 protein | Regrowth | Activation | Lethality | Kinases | Synergism | Mcl-1 protein | Endothelial cells | 1-Phosphatidylinositol 3-kinase | Angiogenesis | Signal transduction | Signaling | Cell activation | Inhibitors | Inhibition | Prostate | Cancer | Apoptosis
Journal Article